Association of Symptomatic Hearing Loss with Functional and Cognitive Recovery 1 Year after Intracerebral Hemorrhage.

"Disclosure: Ms. Abramson, Dr. Castello, Ms. Keins, Ms. Kourkoulis, Dr. Gurol and Dr. Viswanathan report no disclosures. Dr. Greenberg is supported by NIH R01AG26484. Dr. Christopher D. Anderson is supported by NIH R01NS103924, U01NS069763, the American Heart Association (AHA) (18SFRN34250007), the AHA-Bugher Foundation, receives sponsored research support from Massachusetts General Hospital and Bayer AG, and consulting for ApoPharma and Invitae. Dr. Rosand is supported by the AHA-Bugher Foundation, by NIH R01NS036695, UM1HG008895, R01NS093870, R24NS092983, and has consulted for Boehringer Ingelheim. Dr. Biffi is supported by Massachusetts General Hospital, the AHA-Bugher Foundation, and by NIH K23NS100816."

"The authors’ work on this study was supported by funding from the US National Institute of Health (K23NS100816, R01NS093870, R01NS103924, and R01AG26484). The funding entities had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Disclosure: Ms. Abramson, Dr. Castello, Ms. Keins, Ms. Kourkoulis, Dr. Gurol and Dr. Viswanathan report no disclosures. Dr. Greenberg is supported by NIH R01AG26484. Dr. Christopher D. Anderson is supported by NIH R01NS103924, U01NS069763, the American Heart Association (AHA) (18SFRN34250007), the AHA-Bugher Foundation, receives sponsored research support from Massachusetts General Hospital and Bayer AG, and consulting for ApoPharma and Invitae. Dr. Rosand is supported by the AHA-Bugher Foundation, by NIH R01NS036695, UM1HG008895, R01NS093870, R24NS092983, and has consulted for Boehringer Ingelheim. Dr. Biffi is supported by Massachusetts General Hospital, the AHA-Bugher Foundation, and by NIH K23NS100816."